[1]岳麓,程文英,刘伟填.125I籽源组织间照射在肿瘤治疗中的应用[J].国际放射医学核医学杂志,2001,25(1):23-26,41.
　YUE Lu.Implantation with 125I seeds for the treatment of tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(1):23-26,41.
点击复制

125I籽源组织间照射在肿瘤治疗中的应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
25
期数:
2001年第1期
页码:
23-26,41
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
Implantation with 125I seeds for the treatment of tumor
作者:
岳麓;  程文英;  刘伟填
200032 上海, 复旦大学放射医学研究所
Author(s):
YUE Lu
Institute of Radiation Medicine, FuDan University Shanghai, 200032, China
关键词:
近距离组织间照射; 125I; 肿瘤治疗
Keywords:
interstitial brachytherapy; iodine-125; treatment of tumor
分类号:
R817.8
摘要:
125I的生物物理学特征适用于组织间放疗。在国外,用125I组织间照射治疗恶性肿瘤已有较广泛的应用,尤其是将125I籽源植入作为一种独特的方法用于治疗前列腺癌已经相当成熟,但是在其他肿瘤的治疗方面还处于研究阶段。
Abstract:
Thc 125I with special biological and physical characters is available to interstitial brachytherapy. The 125I seeds implantation is widely used in treating malignant tumor abroad. Implantation with 125I seeds is an important and effective method in the treatment of prostate cancer, but it is performed as pilot study in the treatment of other tumors.

参考文献/References:

[1] Lazarescu GR,Battista JJ.Analysis of the radiobiolo-gy of Ytterbium-169 and Iodine-125 permanent brachytherapy implants[J].Phys Med Biol,1997,42:1727-1736.
[2] Ling CC.Permanent implams using Au-198,Pd-103 and I-125:Radiobiological considerations based on the linear quadratic model[J].Int J Radiat Oncol Biol Phys,1992,23:81-87.
[3] Kim JH,Hilaris BS.Iodinc-125 sourcc in interstitial tumor therapy[J].Radiology,1975,123:163-169.
[4] Anderson LL,Kuan HM,Ding IY.Clinical dosimetry with I-125[A].In Gorge[ed].Modern interstitial and intracavitary radation cancer management[C].New York:Masson Publishing,1981.
[5] Williamson JF.Physics of brachythcrapy[A].Perez CA,Brady LW[ed].Principles and practice of radia-tion oncology[C].Third Edition,Philadelphia:Lip-pincott-Raven,1997
[6] Nath R,Anderson LL,Meli JA,et al.Code of prac-tice for brachytherapy physics:Report of the AAPM radation therpy committee task group NO.56[J].Med Phys,1997,24:1557-1579.
[7] Wu A,Zwicker D,Sternick ES.Tumor dose specifi-cation of I-125 seed implants[J].Med Phys,1985,12:27-31.
[8] Chen Y,Stanton RE,Holst RJ,et al.Treatment planning for prostate implant with loose seeds[J].Med Phys,1997,24:1141-1145.
[9] Nath R,Anderson LL,Luxton G,et al.Dosimetry of interstitial brachtherapy sources:Recommendations of the AAPM radiation therapy committee task group NO.43[J].Med Phys,1995,22:209-233.
[10] Williamson JF,Courscy BM,DeWerd LA,et al.Guidence to users of Nycomed Amersham and North American Scientific,Inc,I-125 interstitial sources:Dosimetry and calibration changes:Recommendations of the American Association of physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on low-energy[J].Med Phys,1999,26:570-573.
[11] Kleinberg L,Wallner K,Roy J,et al.Treatment-re-lated srmptoms during the first year following transperineal I-125 prostate implanation[J].Int J Ra-diat Oncol Biol Phys,1994,28:985-990.
[12] Wallner K,Roy J,Harrison L.Low risk of periopera-tive infection without pfophylactic for transperineal prostate brachytherapy[J].Int J Radiat Oncol Biol Phys,1996,36:681-683.
[13] Beyer DC,Priestley JB.Biochemical disease-free sur-vival following I-125 prostate implantation[J].Int J Radiat Oncol Biol Phys,1997,37;559-563.
[14] Ohorio M,Wheler TM,Scardino PT.The new American Joint Committee on Cancer and InternationalUnion Against Cancer TNM classification of prostate cancer[J].Cancer.1994,73:104-114.
[15] Armstrong JG,Anderson LL,Harrison LB.Treat-ment of liver metastases from colorectal cancer with radioactive implants[J].Cancer,1994,73:1800-1804.
[16] Martinez-Monge R,Nag S,Nieroda CA,et al.Io-dine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastic to the liver[J].Cancer,1999,85:1218-1225.
[17] Chen A,Galloway M,Landreneau R,et al.Intraop-erative I-125 brachytherapy for high-risk stage I non-small cell lung carcinoma[J].Int J Radiat Oncol Biol Phys,1999,44:1057-1063.
[18] Mittal BB,Nemcek AA,Sider L.Malignant tumors invading chest wall:Treatment with CT-directed im-plantation of radioactive seeds[J].Radiology,1993,186:901-903.
[19] Schuricht AL,Spitz F,Barbct D,et al.Intraoperative radiotherapy in the combined modality management of pancreatic cancer[J].Am Surg,1998,1043-1049.

相似文献/References:

[1]法逸华.125I粒子近距离照射在肿瘤治疗中的应用[J].国际放射医学核医学杂志,2003,27(3):115.
　FA Yi-hua.Brachytherapy with 125I seeds for the treatment of tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):115.
[2]查金顺.恶性肿瘤术中组织间永久植入125I粒子放疗[J].国际放射医学核医学杂志,2002,26(5):227.
　ZHA Jin-shun.Tumor intra-operative interstitial permanent implantation radiation ther apy with 125I seeds[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(1):227.

备注/Memo

备注/Memo:
收稿日期:2000/8/15。
作者简介:岳麓(1971-),男,山东济南人,复旦大学放射医学研究所(原上海医科大学放射医学研究所)第三研究室硕士研究生,主要从事实验肿瘤及放射敏感性的研究。
更新日期/Last Update: 1900-01-01